🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and effectiveness of a ...
Status
Completed
Location
Multiple Locations
Start Date
2001-03
Trial ID
NCT00253214
Treatments Being Tested
The purpose of this open-label, single dose, two-treatment, two-period, cro...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00645554
Treatments Being Tested
Cognitive impairment after stroke is common and has a major effect on morbi...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT01129479
Treatments Being Tested
The main objective of this non-interventional study was to document the lon...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT01009476
Treatments Being Tested
This will be a double-blind, placebo-controlled, study using daily doses of...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2002-12
Trial ID
NCT00181675
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of galanta...
Status
Completed
Location
Multiple Locations
Start Date
1998-12
Trial ID
NCT00261573
Treatments Being Tested
This study will examine whether extended release galantamine, a drug approv...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2008-09
Trial ID
NCT00741598
Treatments Being Tested
Objectives: The purpose of this study was to investigate the effects of hig...
Status
Completed
Location
Istanbul Medipol University
Start Date
2016-09-01
Trial ID
NCT05102045
The purpose of this study is to evaluate the efficacy and safety of two fix...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00814801
Treatments Being Tested
The aim of this study is to test whether the attention-enhancing effects of...
Status
Completed
Location
University of Maryland School of Medicine, Maryland Psychiatric Research Center
Start Date
2014-09
Trial ID
NCT02420327